AFFYMETRIX (AFFX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AFFYMETRIX (AFFX)

AFFX 14.01

0.0%

Apr 1 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: lwd who wrote (1458)	1/26/2001 6:21:25 AM
From: nigel bates	Read Replies (1) of 1728

I would have posted the AFFX rebuttal, but it came after I went to bed. I'm a little confused by this - The Court found that a "discrete cell location" or "predefined region" implied activation using an energy source (as used by Incyte) for both the '934 and '305 patents, the United States Patent and Trademark Office has recently allowed additional claims in Affymetrix' patent applications without this limitation. The Court's interpretation combined with the recent notices of allowance establish that Affymetrix' family of array patents covers arrays made by a wide variety of techniques for in situ synthesis and deposition of pre-formed polynucleotides Can anyone clarify ? nig

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next